Enliven Therapeutics (ELVN) Common Equity (2019 - 2026)
Enliven Therapeutics' Common Equity came in at $895.15 million for Q2 2026, up 83.3% from $488.47 million a year earlier and up 97.4% from the prior quarter.
Powered by 
Analysis
Enliven Therapeutics (ELVN) Common Equity (2019 - 2026) Analysis & Trends
At the end of FY2025, Enliven Therapeutics' Common Equity was $459.6 million, up 48.3% from FY2024.
- Common Equity carries a five-year compound annual growth rate of 40.3% (FY2020 to FY2025).
- Going back by year, Common Equity was $309.85 million in FY2024 (+26.0%), $245.91 million in FY2023, -$76.83 million in FY2022 and -$42.89 million in FY2021.
- The Q2 2026 figure represents the highest quarterly Common Equity in data going back to Q1 2019.
- Year-over-year, Common Equity has increased for five consecutive quarters, with growth averaging 42.6% over the last eight quarters.
- The fastest year-over-year change in Common Equity over five years came in Q2 2026 (growth of 83.3%), and the weakest in Q1 2025 (a decline of 9.3%).
- Business Quant data shows ELVN's Common Equity at $453.37 million (Q1 2026), $459.6 million (Q4 2025) and $476.12 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Enliven Therapeutics | 3.37 Bn | 3.37 Bn | - | 895.15 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 895.15 Mn |
| Mar 31, 2026 | 453.37 Mn |
| Dec 31, 2025 | 459.60 Mn |
| Sep 30, 2025 | 476.12 Mn |
| Jun 30, 2025 | 488.47 Mn |
| Mar 31, 2025 | 288.30 Mn |
| Dec 31, 2024 | 309.85 Mn |
| Sep 30, 2024 | 288.40 Mn |
| Jun 30, 2024 | 304.93 Mn |
| Mar 31, 2024 | 317.71 Mn |
| Dec 31, 2023 | 245.91 Mn |
| Sep 30, 2023 | 261.75 Mn |
| Jun 30, 2023 | 278.99 Mn |
| Mar 31, 2023 | 291.42 Mn |
| Dec 31, 2022 | -76.83 Mn |
| Sep 30, 2022 | -68.10 Mn |
| Jun 30, 2022 | -58.71 Mn |
| Mar 31, 2022 | -50.61 Mn |
| Dec 31, 2021 | -42.89 Mn |
| Sep 30, 2021 | 99.37 Mn |
API Access
Enliven Therapeutics Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=ELVN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "ELVN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=ELVN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();